NCT01087658 - Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Colorectal Neoplasms

Interventions

DRUG

Glutamine

Per os

DRUG

Calcium and Magnesium

Intravenous

Trial Locations (14)

Investigational Site Number 0001, Greenfield Park

Investigational Site Number 124-005, Laval

Investigational Site Number 124-007, London

Investigational Site Number 124-014, Moncton

Investigational Site Number 124-006, Montreal

Investigational Site Number 124-004, Montreal

Investigational Site Number 124010, Montreal

Investigational Site Number 124-011, Montreal

Investigational Site Number 124-015, Oshawa

Investigational Site Number 124-012, Ottawa

Investigational Site Number 124-003, Québec

Investigational Site Number 124-017, Rimouski

Investigational Site Number 124-002, Toronto

Investigational Site Number 124-016, Winnipeg